← Leaderboards
Weston Daniel
Evoq Therapeutics, Inc.
$4,557,243
Attributed
$4,557,243
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2023–25$2.5M$1.9M$1.3M$625K$0
'23
'24
'25
Funding mix
By agency
NIH$4,557,243 · 3
By mechanism
R44$4,557,243 · 3
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Manufacture”
- Cyrus Wadia · Activate Global, Inc.$31,489,493
- Tim A Bertram · Wake Forest University School Of Medicine$30,163,580
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Kevin Saunders · Duke University$18,106,404
- Suma Babu · Massachusetts General Hospital$17,050,216
- Sabrina Paganoni · Massachusetts General Hospital$17,050,216
Research focus
ManufactureMouse ModelInsulin-Dependent Diabetes MellitusLymph NodesGood Laboratory PracticeManufacturing ProcessExperimental Autoimmune EncephalomyelitisImmune ResponseEvaluationLaboratoriesFeedbackAntigensImmune ToleranceInflammatoryDendritic CellsBystander SuppressionCytokineHigh Density LipoproteinsAutoimmune DiseasesDoseAntigen PresentationEpitopesAnalytical MethodNanodisk
Grant awards (5)
NanoDiscs for Immune Modulation in Celiac Disease$1,050,000
R44 · FY2025 · AI · contact PI
Novel immunotherapy against MOG antibody disease$988,943
R44 · FY2025 · TR · contact PI
Novel immunotherapy against MOG antibody disease$1,000,000
R44 · FY2024 · TR · contact PI
New approach for immune modulation against T1D$756,491
R44 · FY2024 · DK · contact PI
New approach for immune modulation against T1D$761,809
R44 · FY2023 · DK · contact PI